CREDIT ANALYSIS REPORT

SUNWAY BERHAD & SUNWAY TREASURY SUKUK SDN BHD - 2023

Report ID 60538900469598 Popularity 256 views 81 downloads 
Report Date Nov 2023 Product  
Company / Issuer Sunway Bhd Sector Property
Price (RM)
Normal: RM500.00        
  Add to Cart
Rationale
Rating action         

MARC Ratings has assigned ratings to Sunway Group’s existing unrated sukuk and unrated debt as follows:

  • Sunway Berhad’s RM5.0 billion Perpetual Sukuk Programme at AIS
  • Sunway Treasury Sukuk Sdn Bhd’s RM10.0 billion Islamic Medium-Term Notes (IMTN) Programme at AA-IS.
MARC Ratings has concurrently affirmed the existing ratings on Sunway Group’s following programmes:

  • Sunway’s RM2.0 billion Commercial Papers/Medium-Term Notes (CP/MTN) Programme at MARC-1/AA-/Stable
  • Sunway Treasury Sukuk’s RM10.0 billion ICP/IMTN Programme at MARC-1IS(cg)/AA-IS(cg)/Stable
The outlook on all ratings is stable

Rationale

The two-notch rating differential between the perpetual sukuk and Sunway’s long-term senior unsecured rating of AA-/Stable is in line with MARC Ratings’ rating methodology on subordinated instruments. As the current outstanding of RM600.0 million under the Perpetual Sukuk programme was fully subscribed by a single investor and majority shareholder of Sunway, the perpetual sukuk is classified as a financial liability under MFRS 132. In light of this, the group has proposed subsequent issuances to third-party investors that would allow for a 50% equity credit on the perpetual sukuk if it complies with the features highlighted in the aforementioned methodology. 

Issuances under the rated programmes in the near term will be used to fully refinance the outstanding perpetual sukuk. Group borrowings stood at RM9.8 billion as at end-1H2023 (2022: RM9.1 billion), translating to a gross debt-to-equity (DE) ratio of 0.7x. Borrowings are projected to hover around RM10.0 billion to RM11.0 billion over the medium term.

MARC Ratings has considered Sunway’s strong market position and its well-established operating track record across key business segments — property development, property investment, and construction — as key rating drivers. Ongoing property development projects with a combined gross development value (GDV) of RM10.7 billion — domestic projects (RM4.5 billion), Singapore (RM6.1 billion), China (RM0.1 billion) — and unbilled sales of RM4.9 billion as at end-June 2023 provide earnings visibility over the medium term. The projects achieved an overall take-up rate of 66% as at end-June 2023. In Singapore, its two residential projects, just launched in 1H2023, have received encouraging response. Property investment recorded strong improvement due to higher rental income following the cessation of rebates given during the pandemic period. Its hospitality segment, which recorded higher room rates and occupancy levels, also contributed to the improvement. MARC Ratings expects this segment’s performance to benefit from a rebound in tourism following the recent move to liberalise visas for tourists from major countries.

Sunway’s construction segment has sustained its order book above about RM5.0 billion since 2018; order book stood at RM5.8 billion as at end-June 2023, of which major contracts are for a data centre in Johor (RM1.6 billion) and work packages under the Johor-Singapore Rapid Transit System (RTS) Link (RM587 million). MARC Ratings notes the construction margin of between 11%-15% in recent years, which is higher than most of its peers and supported by internal contracts for property investment. Given the group’s strong track record in construction, its order book could improve from the expected increase in rollout of infrastructure projects in 2024.

Sunway has a growing domestic market presence in the healthcare sector, with 845 licensed beds at its two existing medical centres — Sunway Medical Centre Sunway City and Sunway Medical Centre Velocity. By 2H2024, Sunway is expected to have a total of five medical centres with potential capacity of about 2,300 beds. Its healthcare segment, which is undertaken on a joint venture (JV) basis by Sunway Healthcare Group, is forecast to incur capex of about RM1.3 billion for its expansion. This segment could grow sharply if the group were to undertake any mergers and acquisitions. Notwithstanding this strength, the healthcare segment could incur higher debt to fund its expansion plans.

For 1H2023, group revenue grew by 14% y-o-y to RM2.7 billion, while pre-tax profit rose marginally y-o-y to RM395.0 million due to higher operating and financing costs. Given borrowings are not expected to decline over the near-to-medium term, the rating agency expects the group to balance its funding requirement against its cash flow generation ability. Cash and bank balances of RM2.1 billion as at end-June 2023 provide some liquidity buffer.

Rating outlook

The stable outlook reflects our expectation that Sunway will broadly maintain its credit profile within the current levels over the next 12 months.

Rating trajectory

Upside/Downside scenarios

Any upgrade would depend on sustained performance metrics of key businesses, among which are improvement in leverage position to below 0.5x and cash flow interest coverage of above 3.0x. However, the rating could come under pressure on any sharp decline in earnings performance that leads to weakening in key credit metrics that are not commensurate with the rating band.

Key strengths
  • Key domestic player in the property and construction industries
  • Well-established operating track record 
  • Healthy construction order book and strong earnings visibility
Key risks
  • Managing leverage position
  • Slowing property demand due to higher interest rates
Related